Hemostatix Medical Technologies

Hemostatix Medical Technologies is a surgical medical device company focused on thermal scalpel systems that enable surgeons to cut tissue while simultaneously coagulating blood vessels. Its core product, the Hemostatix Thermal Scalpel System, is designed to preserve the precision of a traditional steel scalpel while reducing blood loss, improving visualization, and limiting muscle stimulation and surgical smoke. The company obtained FDA 510(k) clearance for its disposable handle and blade configurations and had earlier clearances for prior versions of the system. Hemostatix was acquired by C2Dx effective January 1, 2022, and its product line, employees, and customer contracts were integrated into C2Dx while manufacturing and distribution remained in the Memphis, Tennessee region. The business is therefore best characterized as an acquired operating surgical device business rather than an independent biotech or pharma developer.